Items where authors include "Bottomley, A"
Up a levelArticle
Musoro, JZ, Coens, C, Sprangers, MAG et al. (18 more authors) (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European Journal of Cancer, 188. pp. 171-182. ISSN 0959-8049
Pe, M, Alanya, A, Falk, RS et al. (25 more authors) (2023) Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures. The Lancet Oncology, 24 (6). e270-e283. ISSN 1470-2045
Cocks, K, Wells, JR, Johnson, C et al. (15 more authors) (2023) Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer, 178. pp. 128-138. ISSN 0959-8049
Gilbert, A orcid.org/0000-0002-9142-1227, Piccinin, C, Velikova, G orcid.org/0000-0003-1899-5942 et al. (4 more authors) (2022) Linking the European Organisation for Research and Treatment of Cancer (EORTC) Item Library to the Common Terminology Criteria for Adverse Events (CTCAE). Journal of Clinical Oncology, 40 (32). pp. 3770-3780. ISSN 0732-183X
Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]. Lung Cancer, 171. p. 126. ISSN 0169-5002
Machingura, A, Taye, M, Musoro, J et al. (19 more authors) (2022) Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: validation study. European Journal of Cancer, 170. pp. 1-9. ISSN 0959-8049
Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. ISSN 0169-5002
Sztankay, M, Wintner, LM, Roggendorf, S et al. (10 more authors) (2022) Developing an e-learning course on the use of PRO measures in oncological practice: health care professionals' preferences for learning content and methods. Support Care Cancer, 30 (3). pp. 2555-2567. ISSN 0941-4355
Gamper, EM, Musoro, JZ, Coens, C et al. (9 more authors) (2021) Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials. BMC cancer, 21 (1). 1083. ISSN 1471-2407
Dirven, L, Musoro, JZ, Coens, C et al. (13 more authors) (2021) Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-Oncology, 23 (8). pp. 1327-1336. ISSN 1522-8517
Calvert, M, King, M, Mercieca-Bebber, R et al. (43 more authors) (2021) SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open, 11 (6). e045105. ISSN 2044-6055
Musoro, JZ, Sodergren, SC, Coens, C et al. (11 more authors) (2020) Minimally important differences for interpreting the EORTC QLQ‐C30 in advanced colorectal cancer patients treated with chemotherapy. Colorectal Disease, 22 (12). pp. 2278-2287. ISSN 1462-8910
Musoro, JZ, Coens, C, Greimel, E et al. (10 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Gynecologic Oncology, 159 (2). pp. 515-521. ISSN 0090-8258
Musoro, JZ, Coens, C, Singer, S et al. (12 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer. Head & Neck, 42 (11). pp. 3141-3152. ISSN 1043-3074
Terada, M, Nakamura, K, Martinelli, F et al. (9 more authors) (2020) Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer. Japanese Journal of Clinical Oncology. ISSN 0368-2811
Bjelic-Radisic, V, Cardoso, F, Cameron, D et al. (20 more authors) (2020) Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Annals of Oncology, 31 (4). p. 552. ISSN 0923-7534
Coens, C, Pe, M, Dueck, AC et al. (32 more authors) (2020) International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. The Lancet Oncology, 21 (2). e83-e96. ISSN 1470-2045
Bjelic-Radisic, V, Cardoso, F, Cameron, D et al. (34 more authors) (2020) An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Annals of Oncology, 31 (2). pp. 283-288. ISSN 0923-7534
Mierzynska, J, Taye, M, Pe, M et al. (14 more authors) (2020) Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer. European Journal of Cancer, 125. pp. 69-82. ISSN 0959-8049
Mierzynska, J, Piccinin, C, Pe, M et al. (10 more authors) (2019) Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. The Lancet Oncology, 20 (12). e685-e698. ISSN 1470-2045
Bottomley, A, Reijneveld, JC, Koller, M et al. (30 more authors) (2019) Current state of quality of life and patient-reported outcomes research. European Journal of Cancer, 121. pp. 55-63. ISSN 0959-8049
Musoro, JZ, Coens, C, Frederic, F et al. (9 more authors) (2019) Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer. JNCI: Journal of the National Cancer Institute, 3 (3). pkz037. ISSN 0027-8874
Bottomley, A, Pe, M, Sloan, J et al. (38 more authors) (2018) Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15 (6). pp. 624-630. ISSN 1740-7745
Musoro, JZ, Bottomley, A, Coens, C et al. (8 more authors) (2018) Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. European Journal of Cancer, 104. pp. 169-181. ISSN 0959-8049
Pe, M, Dorme, L, Coens, C et al. (29 more authors) (2018) Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. The Lancet Oncology, 19 (9). E459-E469. ISSN 1470-2045
Musoro, ZJ, Hamel, J-F, Ediebah, DE et al. (10 more authors) (2018) Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol. BMJ Open, 8 (1). e019117.
Bottomley, A, Pe, M, Sloan, J et al. (36 more authors) (2016) Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncology, 17 (11). e510-e514. ISSN 1470-2045
Wintner, LM, Sztankay, M, Aaronson, N et al. (8 more authors) (2016) The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual. European Journal of Cancer, 68. pp. 73-81. ISSN 0959-8049
Ghislain, I, Zikos, E, Coens, C et al. (11 more authors) (2016) Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. The Lancet Oncology, 17 (7). e294-e304. ISSN 1470-2045
Zikos, E, Coens, C, Quinten, C et al. (16 more authors) (2016) The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. Journal of the National Cancer Institute, 108 (5). ISSN 0027-8874
Quinten, C, Coens, C, Ghislain, I et al. (17 more authors) (2015) The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. European journal of cancer, 51 (18). 2808 - 2819. ISSN 0959-8049
Conference or Workshop Item
Piccinin, C, Bottomley, A, Velikova, G orcid.org/0000-0003-1899-5942 et al. (4 more authors) (2021) Coverage of symptomatic toxicities from the common terminology criteria for adverse events (CTCAE) framework within the european organization for research and treatment of cancer (EORTC) item library. In: 2021 ASCO Annual Meeting, 04-08 Jun 2021, Virtual.
Bjelic-Radisic, V, Cardoso, F, Weis, J et al. (20 more authors) (2021) Adaption of the EORTC quality of life breast cancer module for male breast cancer - phase I. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas.
Schmidt, H, Wintner, LM, Roggendorf, S et al. (10 more authors) (2020) 3029 Development of an E-Learning Course on EORTC Patient Reported Outcome Measures in Clinical Practice: Rationale and study design of Phase I content generation. In: 27th Annual Conference of the International Society for Quality of Life Research, 19-23 Oct 2020, Online.
Sztankay, M, Wintner, LM, Roggendorf, S et al. (10 more authors) (2020) 3030 Creating User-Relevant Content for an E-Learning Course on EORTC Patient-Reported Outcome Measures in Clinical Practice: Results of the Qualitative Analyses of Stakeholder Perspectives. In: 27th Annual Conference of the International Society for Quality of Life Research, 19-23 Oct 2020, Online.
Machingura, A, Musoro, J, Ringash, J et al. (29 more authors) (2020) 3167 Clustering of EORTC QLQ-C30 health-related quality of life scales across several disease sites. In: 27th Annual Conference of the International Society for Quality of Life Research, 19-23 Oct 2020, Online.
Piccinin, C, Bottomley, A, Groenvold, M et al. (3 more authors) (2020) B202.7 Use of the Common Terminology Criteria for Adverse Events (CTCAE) framework to summarize symptomatic toxicities in the European Organisation for Research and Treatment of Cancer (EORTC) Item Library. In: 27th Annual Conference of the International Society for Quality of Life Research, 19-23 Oct 2020, Online.
Bjelic-Radisic, V, Cardoso, F, Velikova, G orcid.org/0000-0003-1899-5942 et al. (7 more authors) (2020) Abstract OT3-16-01: Follow-up in early (EBC) and locally advanced (LABC) breast cancer patients; EORTC protocol 1617-QLG-BCG-ROG. In: 2019 San Antonio Breast Cancer Symposium, 10-14 Dec 2019, San Antonio, Texas.
Proceedings Paper
Machingura, A, Musoro, J, Taye, M et al. (19 more authors) (2022) Does baseline health-related quality of life scores (QLQC30) add prognostic value beyond clinical measures and improve prognostic accuracy in cancer RCTs? In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czech Republic. Springer , S83-S83.
Musoro, JZ, Coens, C, Sprangers, MAG et al. (14 more authors) (2022) Synthesis of anchor-based minimally important differences (MID) for the EORTC QLQ-C30 scales across nine cancer sites. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czech Republic. Springer , S47-S48.
Piccinin, C, Gilbert, A, Groenvold, M et al. (3 more authors) (2022) Clinical characteristics of EORTC item list implementation: A summary based on four years of Item Library use. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czechia. Springer , S114-S115.
Rousta, P, Coens, C, Pe, M et al. (20 more authors) (2022) Minimally Important Differences (MID) by Anchoring to Patients' Rating of Change in Oncology: A Systematic Review. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czechia. Springer , S48.
Machingura, A, Taye, M, Musoro, J et al. (18 more authors) (2021) Does change in health-related quality of life scores (QLQ-C30) add prognostic value beyond clinical measures and improve prognostic accuracy in cancer RCTs? In: Quality of Life Research. 28th Annual Conference of the International Society for Quality of Life Research, 12-28 Oct 2021, Online. Springer Nature , S92-S92.
Piccinin, C, Kulis, D, Bottomley, A et al. (6 more authors) (2019) Development of scientific guidelines for use of the eortc item library in cancer clinical trials. In: Value in Health. ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR, 18-22 May 2019, New Orleans, LA, USA. Elsevier Ltd. , S112-S113.